1153380-07-4

Upstream product

• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 33024-60-1 tetrahydro-2H-pyran-4-ylamine monohydrochloride 
• 38041-19-9 4-aminotetrahydropyran 

Downstream Products

• 1256968-21-4 C₁₈H₁₇N₃O₄ 
• 1256969-34-2 C₂₀H₂₂N₄O₂ 
• 1256968-77-0 C₂₁H₂₀F₃N₃O₄ 
• 1256968-76-9 C₂₁H₂₀N₄O₃ 
• 1256968-72-5 C₂₂H₂₃N₃O₅ 
• 1256968-70-3 C₂₆H₃₁N₃O₃ 
• 1256968-68-9 C₂₁H₂₀F₃N₃O₃ 
• 1256968-66-7 C₂₂H₂₅N₃O₃ 
• 1256967-25-5 5-(benzoxazol-2-yl)-2-trans-cinnamyl-1-(tehrahydropyran-4-yl)benzimidazole 
• 1256968-64-5 C₂₀H₂₀N₄O₅ 
• 1256966-87-6 5-(benzoxazol-2-yl)-2-benzylaminomemyl-1-(tetrahydropyran-4-yl)benzimidazole 
• 1256968-22-5 5-(benzoxazol-2-yl)-2-((tetrahydropyran-4-yl)amino)aniline 
• 1256966-80-9 5-(benzoxazol-2-yl)-2-phenyl-1-(tetrahydropyran-4-yl)benzimidazole 
• 1256966-78-5 5-(benzoxazol-2-yl)-2-cyclohexyl-1-(tetrahydropyran-4-yl)benzimidazole 

Relevant academic research and scientific papers

NOVEL BENZIMIDAZOLE COMPOUND

PROBLEM TO BE SOLVED: To provide a compound having safety and storage stability which can be commercially practical as an active ingredient of a therapeutic agent for a neurodegenerative disease and the like, and a pharmaceutical composition comprising th

NEW CRYSTAL OF BENZIMIDAZOLE COMPOUND, AND PRODUCTION METHOD THEREOF

PROBLEM TO BE SOLVED: To provide a new crystal of 2-[2-methyl-1-(tetrahydro-2H-pyran-4-yl)-1H-benzimidazole-5-yl]-1,3- benzoxazole having excellent storage stability capable of maintaining the same quality, when being stored as a pharmaceutical technical

Direct synthesis of a pde4 inhibitor by using pd-cu-catalyzed c-h/c-br coupling of benzoxazole with a heteroaryl bromide

A short and practical synthetic route of a PDE4 inhibitor (1) was established by using Pd-Cu-catalyzed C-H/ C-Br coupling of benzoxazole with a heteroaryl bromide. The combination of Pd(OAc)2-Cu(OTf)2-PPh3 was found to be

AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS

A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R1 represents (1) a C3-6 alkyl group,(2) a C1-6 alkyl group substituted with one or more substituent group(s) sel